- CMS chooses 6 states for WISeR Model
- Advancing the Field of De-implementation: Perspectives on LV Clinical Preventive Services
- Effectiveness of different de-implementation strategies in primary care
- VA Clinicians’ Perspectives on Low-Value Health Service Use in the Veterans Health Admin
- Choosing wisely and climate crisis: reducing lvc as a strategy to curb environmental impact
- Evaluating the Total Healthcare Cost of Inappropriately Ordered Thyroid Ultrasounds
The CMS Innovation Center will test prior authorization for Medicare coverage of selected services in Arizona, New Jersey, Ohio, Oklahoma, Texas and Washington. Medicare administrative contractors in the states chosen for the Wasteful and Inappropriate Service Reduction demonstration project already have coverage policies for the targeted services and will refer to those policies when deciding whether to approve coverage. Read more.
A recent AJPM article gathers expert input to explore how “de-implementation” strategies might reduce the use of low-value clinical preventive services. It finds that existing frameworks are few, empirical studies are rare, and key obstacles include confusing terminology, potential unintended harms, and limited patient and community engagement. The findings point toward the need for clearer definitions, more research on specific preventive services, and policies that meaningfully involve patients and families in reducing unhelpful care.
This Internal and Emergency Medicine letter to the editor argues that the Choosing Wisely campaign’s efforts to reduce low-value medical care—like unnecessary imaging and antibiotic use—can also lower healthcare’s significant environmental footprint, including greenhouse gas emissions and pharmaceutical pollution. This approach aligns clinical effectiveness with ecological sustainability, offering a pathway where “doing less, when appropriate, is not just good medicine, it is also good planetary stewardship”.
A recent Journal of the Endocrine Society article assessed the cost impact of inappropriately ordered thyroid ultrasounds (TUS) using data from four Mayo Clinic sites between 2017-2021. Though inappropriate TUS patients had similar overall healthcare costs to those with appropriate indications ($13,748 vs. $14,257 at one year), the cascade of downstream procedures—like biopsies and thyroidectomies—added at least $576,000 in direct procedural costs in the cohort studied. The findings suggest that targeting low-value imaging presents a real opportunity for cost savings and resource optimization in health policy.